STRO
Sutro Biopharma Inc
$32.70
0.65 (1.96%) Today
— up— down
Market Cap
$553M+360.8%
Revenue (TTM)
$126.16M+49.9%
Net Income (TTM)
$-270,997,379
$-270,997,379EPS (TTM)
-16.35
-16.35Shares Out
16.57M
16.57MOpen
$33.45
$33.45Previous Close
$33.35
$33.35Day Range
$32.55 – $33.62
$32.55 – $33.6252-Week Range
$6.70 – $43.85
$6.70 – $43.85Beta
1.51
1.51Volume
185.15K
185.15KAvg Volume
280.29K
280.29KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout STRO
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in January 2009.
Related
News
N/A
N/A
Faces of elimination: World Cup fans in their moment of loss - Reuters
Reuters · 1h ago
Major egg producers settle price inflation probe for $3.3 million
CNBC · 1h ago
Trump administration expands list of graduate degrees subject to higher borrowing limits
CNBC · 3h ago
Iran war and AI boom drive wild ride on global markets - Reuters
Reuters · 3h ago
We're selling some shares of a parabolic mover, more than tripling our money
CNBC · 3h ago